STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) - shares |
5 Months Ended | ||
|---|---|---|---|
Nov. 09, 2020 |
Dec. 31, 2020 |
Oct. 27, 2020 |
|
| Sale of Units, net of underwriting discounts (in shares) | 21,525,000 | ||
| Over-allotment option | |||
| Sale of Units, net of underwriting discounts (in shares) | 1,525,000 | ||
| Over-allotment option | Private Placement Warrants | |||
| Sale of Private Placement Warrants (in shares) | 6,500,000 | ||
| Private Placement | |||
| Sale of Private Placement Warrants (in shares) | 4,333,333 | ||
| Private Placement | Private Placement Warrants | |||
| Sale of Private Placement Warrants (in shares) | 4,333,333 |
| X | ||||||||||
- Definition Number of new units issued during the period. No definition available.
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|